Large text / Standard text
Manufacturing Process (GMP)

Caprine serum is sourced from Australasia in view of that region's favourable Transmissible Spongioform Encephalopathy (TSE) profile.

Manufacturing takes place in the United Kingdom and Australia at cGMP. AIMSPRO is listed on the Export Only section of the Australian Therapeutic Goods Register and appropriate Certificates of Pharmaceutical product have been issued, including for North America and Europe.


Back to AIMSPRO
    18 April 08
Clinical Trial Authorisation has been obtained from the...
    20 March 08
Recruitment for the Aimspro Trial for bladder function in Multiple Sclerosis...
    17 March 08
The clinical trial of Aimspro at St George's Hospital was terminated...
Site by